Strengthening drug substance development with robust RSM strategies

Published: 17-Apr-2025

Qixuan Lu, Vice President of Process Chemistry at BioDuro, explains why regulatory starting materials represent the foundation of pharmaceutical manufacturing

You need to be a subscriber to read this article.
Click here to find out more.

Regulatory starting materials (RSMs) are the essential chemical substances that underlie the GMP-compliant synthesis of active pharmaceutical ingredients (APIs).

These components are vital when it comes to defining the structure and quality of the final API (Figure 1).

Selected based on regulatory definitions and scientific rationale, RSMs must be reliably sourced to support the complex, multistep processes that follow.

Their role extends beyond technical aspects; RSMs also act as a critical quality control checkpoint that influences the efficiency, safety and traceability of pharmaceutical manufacturing operations. 

Not yet a Subscriber?

This is a small extract of the full article which is available ONLY to premium content subscribers. Click below to get premium content on Manufacturing Chemist.

Subscribe now Already a subscriber? Sign in here.

You may also like